Determining the optimal interval for imaging surveillance of ascending aortic aneurysms

We reviewed the clinical database of the Maastricht University Medical Centre (MUMC+) for patients who were referred for TAA evaluation between January 1999 and August 2019. Patients with maximal ascending aortic diameters ≥ 40 mm at baseline who underwent multiple imaging examinations during follow-up were included. Exclusion criteria comprised prior aortic or valvular surgery and a diagnosis or suspicion of hereditary connective tissue disease. The study protocol was reviewed and approved by the institutional medical ethics committee, who waived the need for informed consent due to the study’s retrospective nature.

Data collection and image assessment were performed by two readers (B.A., M.R.). Baseline characteristics and medical history were drawn from electronic patient records. Valve morphology and baseline valvular function were determined using transthoracic echocardiography (TTE) and classified according to current guidelines [12, 13].

All TTE, CT angiography, and MRI procedures performed for evaluation of TAA dimensions were assessed to study aortic diameters. Echocardiographic diameters were measured in parasternal long-axis views at end-diastole, using the leading edge-to-leading edge technique. CT and MRI were typically performed using prospective ECG gating with end-diastolic triggering, while measurements were acquired from inner edge to inner edge. For all modalities, care was taken to perform measurements perpendicular to the long axis of the aorta. Mean aneurysm growth rates were calculated by dividing the diameter difference between the first and last imaging examinations by the time interval between the two studies. The primary endpoint was reached when a patient met the indication criterion for pre-emptive surgery. This threshold was set at ≥ 55 mm (tricuspid aortic valve (TAV) and uncomplicated bicuspid aortic valve (BAV)) or ≥ 50 mm (BAV with concomitant risk factors (arterial hypertension, aortic coarctation, family history of dissection and/or expansion rate ≥ 3 mm/year)) [6, 8].

In total, 332 TAA patients (25.3% female) were included (Tab. 1). Median age was 64.2 years (range 19–86 years). Fifty-seven patients (17.2%) had BAV. Compared to those with BAV, patients with TAV were older (65.9 vs 52.4 years, p < 0.001) and more frequently suffered from hypertension (76.4% vs 43.9%, p < 0.001) and hyperlipidaemia (44.0% vs 17.5%, p < 0.001). Patients with BAV more often had moderate or severe aortic stenosis at baseline (28.1% vs 6.9%, p < 0.001).

Median follow-up of the entire cohort was 6.7 years (IQR 4.5–10.2 years). During the cumulative follow-up of 2545.4 years, the included patients underwent 2233 imaging examinations (TTE n = 1750, CT n = 378, and MRI n = 105). Mean time between two consecutive measurements was 1.3 ± 0.7 years. Of the patients who died during follow-up (n = 23), none died of thoracic aortic disease. Two patients suffered dissection and underwent emergency surgery; both had TAV and diameters < 55 mm at last follow-up contact (both < 1 year before dissection onset).

The growth rates of the entire population were 0.14 mm/year (median) and 0.2 ± 0.4 mm/year (mean and SD). The largest observed growth rate was 2.0 mm/year, while 40.6% of patients showed no diameter increase between baseline and last follow-up (Fig. 1). Mean expansion rates were comparable between TAV and BAV (0.2 ± 0.4 mm/year vs 0.2 ± 0.3 mm/year, p = 0.819) (Fig. 2). Women had greater expansion rates than men (0.3 ± 0.5 vs 0.2 ± 0.4 mm/year, p = 0.007). At multivariable regression analysis, female sex and presence of at least moderate aortic regurgitation (AR) at baseline were shown to be independent predictors for more rapid aneurysm expansion (Tab. 2). In contrast, the presence of a BAV was not associated with higher growth rates.

During follow-up, 24 patients (7.2%) reached the indication criterion for pre-emptive surgery. Among those were 9 BAV patients, who all had concomitant risk factors and were referred for aneurysmectomy at a diameter of ≥ 50 mm. Logistic regression revealed baseline diameter, growth rate, and the predetermined interventional threshold to be independent predictors of reaching the primary endpoint (Tab. 3).

Various imaging protocols were tested for their accuracy in timely identification of the necessity for pre-emptive aortic repair (Tab. 4 and 5). Lowering imaging frequencies to less than once annually causes delay to surgery in patients in whom the current diameter is within 5 mm of the surgical threshold. However, imaging intervals can be prolonged safely to once every 3 years, as long as the diameter is between 40 and 44 mm (BAV with risk factors) or 40–49 mm (uncomplicated BAV and TAV). The implementation of such strategies would have reduced the number of imaging examinations in the study population by 16.0% and 29.9%, respectively.

Thus far, studies that sought to investigate aneurysm growth rates have yielded divergent results. Our findings concur with those of recent investigations, which have shown that ascending aortic aneurysms expand at slightly higher rates than the normal-sized aorta (i.e. 0.2–0.4 mm/year vs 0.1 mm/year) [14‐17]. As such, average TAA growth rates are markedly lower than previously assumed [18]. Pioneer work from the Yale group, whose studies form the basis for many recommendations within current guidelines, demonstrated an average enlargement of 0.7–1.2 mm/year [19]. Using serial CT, Hirose et al. even documented growth rates as high as 4.2 mm/year [20]. However, these early studies included a substantial number of patients with connective tissue disease and chronic dissections, who were followed over a relatively short period (i.e. 6–19 months). Since short follow-up durations can cause small diameter changes and measurement inaccuracies to become translated into disproportionally high annual growth rates, it is conceivable that the expansion rates reported in these studies are somewhat overestimated. In comparison, a growth rate of ≥ 0.7 mm/year was observed in only 8.1% of our patient population.

The current study provides more insight into the individual character of TAA progression. Based on reported mean expansion rates, it has long been thought that all aneurysms grow over time [8, 19]. However, our results reflect that nearly half of non-syndromic TAAs remain stable in size—even at long-term follow-up. In contrast, a small portion of patients exhibit remarkably high growth rates (up to eight times the mean) and are at risk for reaching the diameter threshold for preventive surgery. Moderate or severe AR at baseline was shown to be the most important risk predictor for rapid growth. The pathophysiological mechanism behind this observation can be regarded as a vicious circle, in which AR causes increase of left ventricular stroke volumes and elevated aortic wall stress, and further aortic dilatation leads to aggravation of AR. Importantly, we have shown that presence of BAV does not confer risk for more rapid aneurysm dilatation. This, and the observation that BAV is not associated with a higher risk of acute aortic events, may question the lower interventional thresholds that apply to this patient group [3, 21].

Our data confirm that female sex is associated with more rapid aneurysm growth [22]. Moreover, outcome studies have demonstrated that female TAA patients have a three-fold higher risk of experiencing dissection, and a 40% increase in risk of mortality [19, 23]. Although the magnitude of sex-based growth differences does not merit a more frequent imaging strategy in women, it prompts deliberation as to why the natural history of aneurysms differs between genders. One theory explains the worse outcome in women by their higher vessel wall concentrations of matrix metalloproteinases (MMPs)—enzymes involved in the degradation of extracellular matrix (ECM) content. Interestingly, aneurysms with more pronounced MMP‑2 and MMP‑9 expression show more extensive ECM remodelling and decreased compliance [24]. Future immunohistochemical and biomechanical studies could evince a causal relation between gender-associated structural differences and the more aggressive TAA behaviour in women.

Current guidelines prescribe referral for preventive surgery based on absolute diameter cut-offs. In addition, the ACC/AHA advocates elective operation of patients who exhibit growth rates > 5 mm/year. Assessment of these indications requires adequate imaging surveillance, yet only two out of five available guidelines provide appropriateness criteria to this end. Based on the consensus opinion of experts, these recommend yearly or semi-annual CT or MRI [6, 7]. Although others cautiously suggest lowering imaging frequencies in the case of stable disease, no previous study systematically investigated the impact of different follow-up protocols. The results of the current study reveal that yearly imaging carries no therapeutic consequences for patients with small aneurysms. On the contrary, it can add unjustifiable costs to health care and unnecessary exposure to radiation and contrast agent administration. Here, we propose a surveillance strategy that consists of 3‑yearly imaging of patients with smaller aneurysms and yearly imaging of those who are in close proximity to their respective surgical thresholds. We conclude that this approach is as accurate as annual follow-up and reduces the number of requested imaging examinations by 29.9% (TAV) and 16.0% (BAV with risk factors). It is noteworthy that these percentages have been calculated using data of patients who met the endpoint of prophylactic surgery. The proposed strategy could have reduced imaging frequencies by up to two-thirds in patients with stable diameters.

Although current guidelines primarily depend on maximal diameter cut-offs, it is generally known that ATAAD can also occur in aortas that do not meet criteria for pre-emptive surgical repair [25]. Recent studies have investigated the predictive potential of aortic length and volume, and found that these may improve the timely identification of patients at risk [26, 27]. Furthermore, four-dimensional (4D) flow MRI is emerging as a clinically feasible imaging technique that can further improve selection of patients who may benefit from prophylactic surgery [28, 29]. Future prospective studies are now needed for these novel imaging markers to find their way into clinical guidelines.

Some limitations of the current study need to be addressed. First, our study population is not representative of patients with connective tissue diseases. These are reported to have higher aortic growth rates, and the proposed imaging intervals should not be extrapolated to this patient group [30]. Second, we have only looked into growth rates of ascending aortic aneurysms. Descending thoracic and abdominal aneurysms may expand more rapidly and merit more frequent surveillance imaging. Since we included only patients who underwent imaging at ≥ 2 different time points, we were not able to adequately evaluate the risk of adverse outcomes. Third, diameters were assessed using different imaging modalities. Although leading edge-to-leading edge (TTE) and inner edge-to-inner edge (CT and MRI) measurements closely agree, incongruity between methods may have contributed to inaccuracies in calculated growth rates [31]. Fourth, growth rates were calculated assuming a linear TAA growth pattern. According to Laplace’s law, wall tension is proportional to the vessel radius for a given blood pressure. Therefore, it has been hypothesised that growth rates become higher as the aorta progressively enlarges [32]. However, a previous study with standardised imaging intervals could not confirm this hypothesis and found that growth rates remained steady during follow-up [15]. Due to the various time points at which our patients were imaged, we were not able to investigate the relationship between aortic size and growth rate in the current study. Finally, this was a single-centre analysis. Future prospective multicentre studies are needed to confirm our results.